4.4 Article

Isolation of a Lysinibacillus fusiformis strain with tetrodotoxin-producing ability from puffer fish Fugu obscurus and the characterization of this strain

期刊

TOXICON
卷 56, 期 4, 页码 640-643

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.toxicon.2010.05.011

关键词

Puffer fish; Fugu obscurus; Tetrodotoxin; Lysinibacillus fusiformis

资金

  1. Shandong Environmental Protective Project [2006063]
  2. Binzhou University [2009ZDL03]

向作者/读者索取更多资源

Six dominant strains were isolated from the livers of the puffer fish Fugu obscurus and were screened for their TTX production-ability Electrospray ionization-mass spectrometry (ESI-MS) analyses revealed that strain B-1 produced TTX and related substances, mouse bioassay revealed that 23.9 mouse units (MU) of toxins were present in 200 ml of broth medium. On the basis of the physiological and biochemical characteristics of this strain and the results of 16S rRNA analysis, strain B-1 was identified as Lysinibacillus fusiformis. (C) 2010 Elsevier Ltd All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
Article Pharmacology & Pharmacy

Assessment of Aflatoxin M1 in human breast and powdered milk in Tehran, Iran

Mohammadhossein Movassaghghazani, Nazanin Shabansalmani

Summary: The study revealed high levels of AFM1 in both breast milk and powdered milk samples in Tehran, with some samples exceeding the established limits. Therefore, monitoring and regulating toxin levels in these products is crucial for maternal and infant health.

TOXICON (2024)

Article Pharmacology & Pharmacy

Integrating network pharmacology and experimental validation to explore the mechanisms of luteolin in alleviating fumonisin B1-induced intestinal inflammatory injury

Defeng Wen, Wantong Han, Quan Chen, Guanhui Qi, Mengling Gao, Pu Guo, Yu Liu, Zhongyuan Wu, Shulin Fu, Qirong Lu, Yinsheng Qiu

Summary: Luteolin can inhibit FB1-induced intestinal inflammatory injury by inhibiting the activation of NF-kappa B and ERK signaling pathways, according to network pharmacology and in vitro experiments.

TOXICON (2024)